Skip Ribbon Commands
Skip to main content
Webcasts and Presentations
NYSE: WSTSee Quotes >>
LAST: 64.13 1:02 p.m. ET
Change: 0.51    .80%
See Chart >>

Shareholders may receive, free of charge, a hard copy of West Pharmaceutical Service's complete audited financial statements by sending a written request to West Pharmaceutical Services, Inc. Attn: Company's Secretary, 530 Herman O. West Drive, Exton, PA 19341.

Latest Releases
11/19/2015 9:41:12 AM
West Appoints George L. Miller Senior Vice President, General Counsel and Corporate Secretary
11/2/2015 8:00:47 AM
West to Showcase Self-injection Systems and Prefillable Syringe Component Expertise at the PDA Universe of Pre-filled Syringes and Injection Devices
10/29/2015 7:00:50 AM
West Announces Third Quarter 2015 Results
Corporate Overview

West Pharmaceutical Services, Inc. is a global pharmaceutical technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products.

West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines.

Internationally headquartered in Exton, Pa., West supports its partners and customers from 50 locations throughout North America, South America, Europe, and the Asia Pacific region.

Investor Contacts

Michael A. Anderson
Vice President and Treasurer

John Woolford
Westwicke Partners